Published in Ochsner J on January 01, 2011
The Relationship between Body Mass Index and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography. Cardiol Res Pract (2017) 0.75
The impact of inflammation on the obesity paradox in coronary heart disease. Int J Obes (Lond) (2016) 0.75
Associations between body fat variability and later onset of cardiovascular disease risk factors. PLoS One (2017) 0.75
Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic Syndrome Prediction in Colombian University Students. Nutrients (2017) 0.75
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord (1998) 7.97
How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol (1996) 7.12
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) (2003) 6.11
Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr (2000) 5.29
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Generalized equations for predicting body density of women. Med Sci Sports Exerc (1980) 4.21
Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr (1991) 3.82
Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res (2000) 3.60
State-level estimates of annual medical expenditures attributable to obesity. Obes Res (2004) 3.20
The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. Int J Obes Relat Metab Disord (2002) 2.95
Human body composition and the epidemiology of chronic disease. Obes Res (1995) 2.93
Limits of body mass index to detect obesity and predict body composition. Nutrition (2001) 2.69
Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA (1978) 2.54
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr (2004) 2.29
Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev (2002) 2.20
Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr (1995) 2.02
The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord (2000) 1.99
The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex. Clin Nutr (2010) 1.79
Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol (1996) 1.74
Sex and age specific prediction formulas for estimating body composition from bioelectrical impedance: a cross-validation study. Int J Obes (1991) 1.71
Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. Nutrition (2003) 1.69
Indirect estimates of body composition are useful for groups but unreliable in individuals. Int J Obes Relat Metab Disord (2000) 1.65
The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens (1989) 1.57
Relationships between the Body Mass Index and body composition. Obes Res (1996) 1.55
Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr (1992) 1.55
Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med (1985) 1.46
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol (2004) 1.44
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol (1997) 1.36
Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol (1985) (1988) 1.36
Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med (2006) 1.21
The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populations. Eur J Clin Nutr (2001) 1.19
Body composition methods: comparisons and interpretation. J Diabetes Sci Technol (2008) 1.15
Relationship between body fat and body mass index: differences between Indonesians and Dutch Caucasians. Eur J Clin Nutr (1998) 1.13
Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc (2006) 1.10
Differences in the relationship between BMI and percentage body fat between Japanese and Australian-Caucasian young men. Br J Nutr (2006) 1.07
Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J (2002) 1.07
Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol (2004) 1.05
Body composition in children and adults by air displacement plethysmography. Eur J Clin Nutr (1999) 1.05
How fat is obese? Acta Diabetol (2003) 1.03
Differences in body-composition assumptions across ethnic groups: practical consequences. Curr Opin Clin Nutr Metab Care (2001) 1.01
Adiposity and cardiovascular disease: are we using the right definition of obesity? Eur Heart J (2007) 1.01
Population differences in body composition in relation to the body mass index. Eur J Clin Nutr (1994) 0.99
Variations in percentage of body fat within different BMI groups in young, middle-aged and old women. Clin Physiol Funct Imaging (2003) 0.97
Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation (2004) 0.97
Regional body volumes, BMI, waist circumference, and percentage fat in severely obese adults. Obesity (Silver Spring) (2007) 0.97
Comparison between bioelectrical impedance analysis and body mass index methods in determination of obesity prevalence in Ahvazi women. Eur J Clin Nutr (2006) 0.96
Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol (1994) 0.95
Practical body composition assessment for children, adults, and older adults. Int J Sport Nutr (1998) 0.94
Obesity in a cohort of black Jamaican children as estimated by BMI and other indices of adiposity. Eur J Clin Nutr (2003) 0.91
Monitoring body fat in the elderly: application of air-displacement plethysmography. Curr Opin Clin Nutr Metab Care (2004) 0.91
The validity of the World Health Organisation's obesity body mass index criteria in a Turkish population: a hospital-based study. Asia Pac J Clin Nutr (2007) 0.88
The relationship between body mass index and per cent body fat in the severely obese. Diabetes Obes Metab (2007) 0.87
Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J (2002) 0.86
Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs. Am Heart J (1994) 0.86
Evaluation of body fat estimated from body mass index and impedance in Belgian male military candidates: comparing two methods for estimating body composition. Mil Med (2008) 0.86
Body mass index as a measure of body fatness in the elderly. Eur J Clin Nutr (1989) 0.85
Prevalence of hostility in young coronary artery disease patients and effects of cardiac rehabilitation and exercise training. Mayo Clin Proc (2005) 0.82
The prediction of body composition in Chinese Australian females. Int J Obes Relat Metab Disord (2001) 0.80
[Predictive accuracy of body mass index in estimating body fatness measured by bioelectrical impedance]. Arch Latinoam Nutr (2004) 0.77
Comparison of the body mass index to other methods of body fat evaluation in ethnic Japanese and Caucasian adolescent girls. Int J Obes Relat Metab Disord (2001) 0.76
Estimation of body density based on hydrostatic weighing without head submersion in young Japanese adults. J Sports Sci (2006) 0.76
Comparison of air displacement plethysmography to hydrostatic weighing for estimating total body density in children. BMC Pediatr (2005) 0.76
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol (2009) 6.23
Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 5.27
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Outcomes of lumbar to sacral nerve rerouting for spina bifida. J Urol (2010) 3.94
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am J Trop Med Hyg (2004) 2.87
Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (2009) 2.83
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus. Am J Cardiol (2012) 2.77
Omega-3 fatty acids for cardioprotection. Mayo Clin Proc (2008) 2.65
Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol (2013) 2.62
Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol (2007) 2.52
Run for your life ... at a comfortable speed and not too far. Heart (2012) 2.48
The obesity paradox, weight loss, and coronary disease. Am J Med (2009) 2.25
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc (2013) 2.10
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol (2005) 2.10
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98
Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc (2009) 1.88
Physical activity promotion in the health care system. Mayo Clin Proc (2013) 1.83
Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol (2003) 1.81
Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol (2003) 1.80
Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc (2010) 1.75
EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation (2012) 1.67
Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol (2012) 1.61
Intensive lipid intervention in the post-ENHANCE era. Mayo Clin Proc (2008) 1.55
Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J (2013) 1.53
Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J (2008) 1.50
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev (2012) 1.47
The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv (2009) 1.47
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol (2002) 1.46
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel? Cardiology (2013) 1.44
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol (2004) 1.44
Stopping stress at its origins. Hypertension (2007) 1.44
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol (2011) 1.41
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant (2009) 1.41
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol (2013) 1.37
The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37
Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc (2009) 1.33
A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol (2011) 1.33
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol (2006) 1.32
Dietary sodium restriction: take it with a grain of salt. Am J Med (2013) 1.30
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys (2011) 1.27
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol (2006) 1.26
A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles. Small (2011) 1.25
Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol (2003) 1.24
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol (2009) 1.23
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol (2007) 1.21
45-Year trends in women's use of time and household management energy expenditure. PLoS One (2013) 1.21
Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med (2006) 1.21
Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr (2008) 1.20
C-reactive protein and cardiovascular diseases--is it ready for primetime? Am J Med Sci (2009) 1.20
Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLoS One (2008) 1.18
Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc (2012) 1.18
Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol (2012) 1.16
Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med (2009) 1.15
Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J (2004) 1.12
The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc (2012) 1.11
Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc (2006) 1.10
Maternal inactivity: 45-year trends in mothers' use of time. Mayo Clin Proc (2013) 1.10
Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 1.10
Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis (2011) 1.10
Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant (2006) 1.10
Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol (2004) 1.10
The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med (2008) 1.09
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc (2013) 1.09
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol (2003) 1.08
The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc (2009) 1.08
Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J (2002) 1.07
Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs. Am J Cardiol (2009) 1.06
Of mice and men: atrial fibrillation in veteran endurance runners. J Am Coll Cardiol (2013) 1.06
Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol (2004) 1.05
Validation of a novel protocol for calculating estimated energy requirements and average daily physical activity ratio for the US population: 2005-2006. Mayo Clin Proc (2013) 1.05
A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev (2013) 1.05
Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev (2011) 1.04
The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev (2008) 1.04
Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol (2002) 1.02